Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer
Kron, A, Alidousty, C, Scheffler, M, Merkelbach-Bruse, S, Seidel, D, Riedel, R, Ihle, M, Michels, S, Nogova, L, Fassunke, J, Heydt, C, Kron, F, Ueckeroth, F, Serke, M, Krüger, S, Grohe, C, Koschel, D,Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy333
Date:
August, 2018
File:
PDF, 817 KB
english, 2018